A detailed history of Pallas Capital Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 6,865 shares of NTRA stock, worth $1.07 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
6,865
Previous 6,469 6.12%
Holding current value
$1.07 Million
Previous $822,000 32.12%
% of portfolio
0.05%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$117.67 - $174.0 $46,597 - $68,904
396 Added 6.12%
6,865 $1.09 Million
Q3 2024

Oct 25, 2024

BUY
$97.75 - $129.67 $220,915 - $293,054
2,260 Added 53.69%
6,469 $822,000
Q2 2024

Jul 19, 2024

BUY
$85.28 - $112.6 $358,943 - $473,933
4,209 New
4,209 $455,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $15.1B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.